FDAnews
www.fdanews.com/articles/157074-fda-grants-qidp-designation-to-eravacycline-tetraphase-s-lead-antibiotic-product-candidate

FDA Grants QIDP Designation to Eravacycline, Tetraphase’s Lead Antibiotic Product Candidate

July 15, 2013
Tetraphase has created an antibiotic, eravacycline, which has received Qualified Infectious Disease Product status from the FDA.
Yahoo! Finance